Menstrual migraine — what supplements actually have evidence
Menstrual migraine is a recognised migraine subtype driven by the estrogen drop at the end of the luteal phase, and the evidence-based supplement layer is the same magnesium, riboflavin, and CoQ10 backbone used for general migraine prevention — an adjunct to, not a replacement for, neurology and women’s health care. Magnesium has the most menstrual-migraine-specific support: a small trial cut attack frequency, duration, and pain when 360 mg/day was taken from cycle day 15 through menses, which is why cycle-timed loading is preferred over steady dosing. Riboflavin 400 mg/day and CoQ10 each have migraine-prevention trial evidence but take 8–12 weeks to work. The key caveat: if attacks don’t fall by roughly half on supplements, prescription perimenstrual mini-prophylaxis or hormonal stabilisation usually outperforms supplements alone, and aura plus age over 35 plus smoking makes estrogen-containing options a stroke risk.
Read this first. Menstrual migraine often warrants prescription mini-prophylaxis (frovatriptan or naratriptan in the perimenstrual window) or hormonal stabilisation (continuous estrogen patch, extended-cycle pills) — these prescription options usually outperform supplements alone. If you have aura with your menstrual migraines and you smoke or are over 35, combined hormonal contraception carries elevated stroke risk and is contraindicated. Coordinate with neurology and women's health.
What actually works in trials
Magnesium (citrate or glycinate)
400–600 mg elemental/day; cycle-timed loading from cycle day 15 through day 5
Magnesium has Tier-1 evidence in general migraine prevention; the Facchinetti 1991 trial in 20 women with menstrual migraine specifically showed reduction in attack frequency, duration, and pain intensity with 360 mg/day taken from cycle day 15 through menses. The cycle-timed loading approach (higher dose in the luteal phase and early menses) is more menstrual-migraine-specific than steady daily dosing. Magnesium citrate has good bioavailability; glycinate has GI advantages.
Riboflavin (B2)
400 mg/day, daily (not cycle-timed)
Riboflavin 400 mg/day has Tier-1 evidence in migraine prevention (Schoenen 1998). Effect is mitochondrial — supporting cerebral energy metabolism. Takes 8–12 weeks to manifest. Daily continuous dosing across the cycle is the standard approach. Bright yellow urine is expected and benign.
CoQ10 (ubiquinol)
100 mg three times daily
CoQ10 300 mg/day has trial-level evidence in migraine prevention (Sandor 2005). Mitochondrial mechanism rationale similar to riboflavin; the two are often combined. Effect over 8–12 weeks. Ubiquinol form has better absorption than ubiquinone, particularly in older women.
Vitamin D3 (in deficient women) and B6 (P5P)
Vit D3 2,000–4,000 IU/day; P5P 25–50 mg/day cycle-timed (luteal phase)
Vitamin D status affects migraine frequency in observational studies; trial-level repletion data are modest but the routine is well-justified. B6 has small RCT signals in PMS/PMDD and as a mild estrogen-metabolism modulator; modest case in menstrual migraine. Avoid chronic high-dose B6 (≥100 mg/day) — sensory neuropathy.
Ginger (acute, at headache onset)
250–500 mg standardised extract at attack onset, may repeat ×1
Ginger has small RCT evidence vs sumatriptan as an acute migraine treatment (Maghbooli 2014). Modest signal, useful for users who can't take triptans, well-tolerated. Ginger also has antiemetic properties relevant to migraine-associated nausea.
Chasteberry (Vitex agnus-castus)
20–40 mg/day standardised extract
Vitex has trial evidence in PMS and modest signals in menstrually-related migraine. Effect is via prolactin and indirectly via luteal-phase progesterone modulation. Effect over 3 cycles; modest. Avoid in users on dopaminergic medications.
The non-supplement layer
- Mini-prophylaxis: frovatriptan or naratriptan in the perimenstrual window has the best prescription evidence base for menstrual migraine prevention.
- Hormonal stabilisation: continuous combined hormonal contraception, transdermal estrogen patches in the perimenstrual window, or hormonal IUD with supplemental estrogen — the right option depends on contraceptive needs and aura status.
- Adequate hydration in the luteal phase: even mild dehydration is a common trigger.
- Sleep regularity across the cycle: irregular sleep amplifies the estrogen-withdrawal trigger.
- Caffeine moderation and consistency: caffeine withdrawal headaches are a common confounder.
What to skip
- Feverfew alone for menstrual migraine — mixed evidence in general migraine, no specific menstrual-migraine signal.
- Butterbur (Petadolex and similar) — once an evidence-based option, but hepatotoxicity concerns led the American Academy of Neurology to drop it from migraine prevention guidance in 2015; product safety screening varies.
- "Hormone balancing" herbal stacks with sub-therapeutic doses of multiple botanicals — read the labels.
- 5-HTP at high doses with concurrent triptan use — serotonin syndrome theoretical risk.
- Megadose B6 (≥100 mg/day chronically) — sensory neuropathy.
- "Estrogen detox" products — not relevant to the estrogen-withdrawal mechanism; many are unstandardised herbs at sub-therapeutic doses.
- Acute "migraine relief" supplement gummies — typically combine sub-therapeutic doses of magnesium and riboflavin that do not address an acute attack.
What to track
A migraine diary across at least 2–3 cycles is the foundation — tracking attack day relative to menses, severity (0–10), duration, triggers, and medication use. Validated tools include MIDAS and HIT-6 for impact, and PedMIDAS for younger users. Reassess supplement regimen at 12 weeks (three menstrual cycles). For magnesium, watch ferritin and stool habit (loose stools at higher doses of citrate). For B6, watch for any new tingling or numbness — sign to reduce dose.
Practical quick-start. Daily magnesium glycinate 300–400 mg elemental; add an extra 200 mg from cycle day 15 through day 5. Riboflavin 400 mg/day continuously. CoQ10 100 mg three times daily. Test 25-OH-D and supplement to 30–50 ng/mL. Track attacks across three cycles. If supplements alone don't reduce frequency by ~50%, escalate to neurology for prescription mini-prophylaxis or hormonal stabilisation.
Educational reference, not medical advice. Menstrual migraine with aura plus age over 35 plus smoking is a stroke-risk combination that warrants careful neurology and women's health input before adding any estrogen-containing intervention.
Sources
- Facchinetti F, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31(5):298–301. PMID: 1860787
- Schoenen J, et al. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50(2):466–470. PMID: 9484373
- Sandor PS, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713–715. PMID: 15728298
- Maghbooli M, et al. Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Phytother Res. 2014;28(3):412–415. PMID: 23657930
- Silberstein SD, et al. Acute and preventative therapy of menstrual migraine. Lancet Neurol. 2004;3(6):354–361. PMID: 15157850
- Pringsheim T, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):S1–S59. PMID: 22683887